Gene · 10148
Papers1,901
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,901
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular Vesicle-Based Drug Delivery Systems for Head and Neck Squamous Cell Carcinoma: A Systematic Review. | Pharmaceutics | 2023 | 37242569 | PubTator, text mining | PubMed |
| Predicting the Progress of Tuberculosis by Inflammatory Response-Related Genes Based on Multiple Machine Learning Comprehensive Analysis. | J Immunol Res | 2023 | 37228444 | PubTator, text mining | PubMed |
| RNA demethylase ALKBH5 suppresses tumorigenesis via inhibiting proliferation and invasion and promoting CD8+ T cell infiltration in colorectal cancer. | Transl Oncol | 2023 | 37224767 | PubTator, text mining | PubMed |
| Significant elevated CXCL14 and decreased IL-39 levels in patients with tuberculosis. | Open Life Sci | 2023 | 37215496 | PubTator, text mining | PubMed |
| Interleukin 35: protective role and mechanism in type 1 diabetes. | Cent Eur J Immunol | 2023 | 37206590 | PubTator, text mining | PubMed |
| Autophagy-related genes analysis reveals potential biomarkers for prediction of the impaired walking capacity of peripheral arterial disease. | BMC Med | 2023 | 37198605 | PubTator, text mining | PubMed |
| Combination of machine learning-based bulk and single-cell genomics reveals necroptosis-related molecular subtypes and immunological features in autism spectrum disorder. | Front Immunol | 2023 | 37168851 | PubTator, text mining | PubMed |
| Epigenetics of Inflammatory Bowel Diseases. | Turk J Gastroenterol | 2023 | 37158530 | PubTator, text mining | PubMed |
| m6A modification on the fate of colorectal cancer: functions and mechanisms of cell proliferation and tumorigenesis. | Front Oncol | 2023 | 37152066 | PubTator, text mining | PubMed |
| The Wheel of p53 Helps to Drive the Immune System. | Int J Mol Sci | 2023 | 37108808 | PubTator, text mining | PubMed |
| Potential of Interleukin (IL)-12 Group as Antivirals: Severe Viral Disease Prevention and Management. | Int J Mol Sci | 2023 | 37108513 | PubTator, text mining | PubMed |
| Neoadjuvant chemotherapy enhances anti-tumor immune response of tumor microenvironment in human esophageal squamous cell carcinoma. | iScience | 2023 | 37091252 | PubTator, text mining | PubMed |
| Monocyte signature as a predictor of chronic lung disease in the preterm infant. | Front Immunol | 2023 | 37090732 | PubTator, text mining | PubMed |
| Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer. | BMC Gastroenterol | 2023 | 37081402 | PubTator, text mining | PubMed |
| Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer. | J Immunother Cancer | 2023 | 37072348 | PubTator, text mining | PubMed |
| Targeting IL-6 trans-signalling: past, present and future prospects. | Nat Rev Immunol | 2023 | 37069261 | PubTator, text mining | PubMed |
| Comprehensive analysis of the expression and prognosis for RAI2: A promising biomarker in breast cancer. | Front Oncol | 2023 | 37064084 | PubTator, text mining | PubMed |
| Staphylococcus aureus induces tolerance in human monocytes accompanied with expression changes of cell surface markers. | Front Immunol | 2023 | 37063823 | PubTator, text mining | PubMed |
| Activated CD90/Thy-1 fibroblasts co-express the Δ133p53β isoform and are associated with highly inflamed rheumatoid arthritis. | Arthritis Res Ther | 2023 | 37060003 | PubTator, text mining | PubMed |
| Hedgehog Signaling Regulates Treg to Th17 Conversion Through Metabolic Rewiring in Breast Cancer. | Cancer Immunol Res | 2023 | 37058110 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10148/papers?page=10